Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Juvenescence
AddedFeb 13, 2024
UpdatedJun 28, 2026
Juvenescence

Juvenescence

Series C

Juvenescence: A biotech firm innovating therapies and products for aging modification and longevity.

HQ
Mobile, AL, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to extend human healthspan and improve quality of life, Juvenescence is a biotech company focused on developing therapies and products aimed at modifying the aging process. The company envisions a future where aging can be managed and mitigated through scientific innovation. Juvenescence offers a range of therapeutic solutions designed to promote longevity and enhance cognitive health, leveraging cutting-edge research in areas such as ketones' impact on performance.

Notable figures affiliated with Juvenescence include Dr. Brianna Stubbs, who has been instrumental in researching the cognitive benefits of ketones. The company has attracted significant investment from leading venture capital firms in the biotech sector. Among its key achievements, Juvenescence has made strides in developing novel therapies that have the potential to revolutionize how aging is treated, thereby making a substantial impact on the field of longevity science.

Juvenescence - Similar Companies

Rejuveron Life Sciences logo

Rejuveron Life Sciences

rejuveron.com

Longeveron logo

Longeveron

longeveron.com

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

Rejuvenation Technologies Inc. logo

Rejuvenation Technologies Inc.

Rejuvenate Bio logo

Rejuvenate Bio

rejuvenatebio.com

AgeX Therapeutics logo

AgeX Therapeutics

Juvena Therapeutics logo

Juvena Therapeutics

BioViva logo

BioViva

Rejuvitas logo

Rejuvitas

rejuvitas.com

Altos Labs logo

Altos Labs

altoslabs.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Retro Biosciences logo

Retro Biosciences

retro.bio

JangoBio logo

JangoBio

jango.bio

Humanity logo

Humanity

humanity.email

Jyzen logo

Jyzen

jyzen.com

Juvenescence - Quick Facts

Who are Juvenescence's competitors?

Companies similar to Juvenescence include Rejuveron Life Sciences, Longeveron, Juventas Therapeutics and Rejuvenation Technologies Inc..

When was Juvenescence founded?

Juvenescence was founded in 2016.

Where is Juvenescence's headquarters located?

Juvenescence's headquarters is located in Mobile, AL, US.

When was Juvenescence's last funding round?

Juvenescence's most recent funding round was for $56.9M (USD) in April 2020.

How much has Juvenescence raised to-date?

As of Apr 17, 2020, Juvenescence has raised a total of $219.2M (USD).

How many employees does Juvenescence have?

Juvenescence has 41 employees as of Feb 5, 2024.

Juvenescence - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Products
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 8620Medical and dental practice activities
Show 19 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 621000Ambulatory Health Care Services
  • 621100Offices of Physicians
  • 621110Offices of Physicians
  • 621111Offices of Physicians (except Mental Health Specialists)
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified